BFRI יחס מהיר Biofrontera, Inc.

Biofrontera Inc. (BFRI) minimizes its environmental footprint through digitalization and compliance with distribution standards. The business leverages its leadership in photodynamic therapy, offering the innovative Ameluz system and BF-RhodoLED lamps to combat skin precancer. The share price history on GURU.Markets shows that the liquidity ratio is 1.11, while the scaling of product output is supported by automated filling lines.

The quick ratio measures a company's ability to meet its immediate obligations using only cash and accounts receivable, excluding slow-moving inventories. Investors analyze this ratio to identify hidden cash gaps and assess the actual margin of financial strength. The trend in the quick liquidity metric demonstrates the readiness of Biofrontera Inc. (BFRI) to withstand operational shocks. This is critical amid aggressive pressure from pharma behemoths, which necessitates significant marketing expenditures.